Factor Xa inhibitors for acute coronary syndromes-Reference-Cited by-同舟云学术

Factor Xa inhibitors for acute coronary syndromes

Published:2011-01-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Brito Viviana¹,Ciapponi Agustín²,Kwong Joey³

Affiliation:

1. Hospital de Clinicas, Universidad de Buenos Aires; Coronary Care Unit; Avenida Cordoba 2351 Piso Sala 1 Ciudad Autonoma Buenos Aires Capital Federal Argentina

2. Institute for Clinical Effectiveness and Health Policy - Hospital Italiano de Buenos Aires; Argentine Cochrane Centre IECS - Family and Community Medicine Service; Dr. Emilio Ravignani 2024 Buenos Aires Capital Federal Argentina C1414CPV - C1181ACH

3. London School of Hygiene & Tropical Medicine; Department of Non-Communicable Disease Epidemiology; Keppel Street London UK WC1E 7HT

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007038.pub2/fullpdf

Reference51 articles.

1. A synthetic factor-xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction: the Pentalyse study;Coussement;European Heart Journal,2001

2. A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study;Simoons;Journal of the American College of Cardiology,2004

3. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes;Fox;Annals of Internal Medicine,2007

4. Abstract Nª V1744: Early benefit of fondaparinux in patients with non-ST elevation acute coronary syndromes: a secondary analysis of the OASIS 5 trial;Genth-Zotz;Clinical Research in Cardiology,2007

5. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial;Mehta;Journal of the American College of Cardiology,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population;Cardiology and Therapy;2022-02-09

2. For people with acute coronary syndrome, how does fondaparinux compare with enoxaparin and unfractionated heparin (UFH)?;Cochrane Clinical Answers;2020-11-01

3. Pentasaccharides for the prevention of venous thromboembolism;Cochrane Database of Systematic Reviews;2016-10-31

4. Idraparinux or Idrabiotaparinux for Long-Term Venous Thromboembolism Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;PLoS ONE;2013-11-20

5. Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?;Current Clinical Pharmacology;2012-06-01